Serge Saxonov - 07 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
07 Dec 2021
Net transactions value
-$2,128,406
Form type
4
Filing time
09 Dec 2021, 16:47:43 UTC
Previous filing
24 Nov 2021
Next filing
30 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $26,253 +5,209 +0.59% $5.04* 889,818 07 Dec 2021 Direct F1
transaction TXG Class A Common Stock Options Exercise $34,865 +3,037 +0.34% $11.48* 892,855 07 Dec 2021 Direct F1
transaction TXG Class A Common Stock Sale $27,772 -200 -0.02% $138.86 892,655 07 Dec 2021 Direct F1
transaction TXG Class A Common Stock Sale $109,075 -766 -0.09% $142.40 891,889 07 Dec 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $456,881 -3,187 -0.36% $143.36 888,702 07 Dec 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $96,950 -672 -0.08% $144.27 888,030 07 Dec 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $83,247 -571 -0.06% $145.79 887,459 07 Dec 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale $952,882 -6,480 -0.73% $147.05 880,979 07 Dec 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale $350,673 -2,370 -0.27% $147.96 878,609 07 Dec 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale $112,043 -754 -0.09% $148.60 877,855 07 Dec 2021 Direct F1, F8
holding TXG Class A Common Stock 4,498 07 Dec 2021 See footnote F9
holding TXG Class A Common Stock 89,960 07 Dec 2021 See footnote F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -5,209 -8.9% $0.000000 53,323 07 Dec 2021 Class A Common Stock 5,209 $5.04 Direct F1, F11
transaction TXG Stock Option (right to buy) Options Exercise $0 -3,037 -5.9% $0.000000 48,596 07 Dec 2021 Class A Common Stock 3,037 $11.48 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $141.77 to $142.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $142.86 to $143.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $144.00 to $144.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $145.34 to $146.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $146.45 to $147.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $147.4621 to $148.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $148.545 to $148.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F10 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F11 This option, originally for 250,000 shares, of which 196,677 have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F12 This option, originally for 145,786 shares, of which 97,190 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.